BALAXI Stock Overview
Balaxi Pharmaceuticals Limited, together with its subsidiaries, engages in the international wholesale distribution of pharmaceuticals, builder’s hardware, and FMCG products in Africa, the Caribbean Islands, and Latin America.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Balaxi Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹599.65 |
| 52 Week High | ₹686.30 |
| 52 Week Low | ₹399.95 |
| Beta | 0.66 |
| 1 Month Change | 5.79% |
| 3 Month Change | 0.41% |
| 1 Year Change | 9.27% |
| 3 Year Change | 2.29% |
| 5 Year Change | 478.81% |
| Change since IPO | 4,293.04% |
Recent News & Updates
Recent updates
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost
Feb 10
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet
Feb 09Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?
Aug 08The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested
May 20A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Feb 03Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Sep 06Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively
Jun 03Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 12Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 27
Shareholder Returns
| BALAXI | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 0.09% | -1.6% | -3.7% |
| 1Y | 9.3% | 53.4% | 38.4% |
Return vs Industry: BALAXI underperformed the Indian Healthcare industry which returned 53.4% over the past year.
Return vs Market: BALAXI underperformed the Indian Market which returned 38.4% over the past year.
Price Volatility
| BALAXI volatility | |
|---|---|
| BALAXI Average Weekly Movement | 7.3% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: BALAXI's share price has been volatile over the past 3 months.
Volatility Over Time: BALAXI's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1942 | 400 | Ashish Maheshwari | balaxipharma.in |
Balaxi Pharmaceuticals Limited, together with its subsidiaries, engages in the international wholesale distribution of pharmaceuticals, builder’s hardware, and FMCG products in Africa, the Caribbean Islands, and Latin America. The company provides pharmaceutical products across various therapeutic areas that mainly treats antibiotics, analgesic, anti-malaria, and others. It also offers biscuits and toothpastes.
Balaxi Pharmaceuticals Limited Fundamentals Summary
| BALAXI fundamental statistics | |
|---|---|
| Market cap | ₹6.12b |
| Earnings (TTM) | -₹52.21m |
| Revenue (TTM) | ₹2.62b |
2.3x
P/S Ratio-116.7x
P/E RatioIs BALAXI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BALAXI income statement (TTM) | |
|---|---|
| Revenue | ₹2.62b |
| Cost of Revenue | ₹1.51b |
| Gross Profit | ₹1.11b |
| Other Expenses | ₹1.16b |
| Earnings | -₹52.21m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.14 |
| Gross Margin | 42.45% |
| Net Profit Margin | -1.99% |
| Debt/Equity Ratio | 12.0% |
How did BALAXI perform over the long term?
See historical performance and comparison